C.LambrightC
Today peptides, tomorrow homeopathy (...though at least for the latter, a presumption of safety would have a more rational basis) Instead of focusing on banning things a small subset of people are using and seeing benefit in, can we focus on modernizing the clinical trial system to promote efficient drug development
You can benefit from retatrutide therapy if: You are obese (BMI 30 kg/m or more) or overweight (BMI 27 kg/m or more) with at least one weight-related health condition
On the one hand, Akkermansia muciniphila enhances the junction strength between intestinal epithelial cells by regulating the expression of tight junction proteins, such as ZO-1, Occludin, and Claudin-1, to attempt to repair the disrupted intestinal barrier (Liu et al., 2023)
Many of these same trials also found favorable impact on kidney health
Hereditary disorders like neurofibromatosis 2 (NF2), schwannomatosis, or Carney complex trigger schwannomas